All Infection Prevention & Control articles – Page 4
-
News Bruke showcases expanding Microbiology & Infection Diagnostics portfolio at ASM Microbe 2026
At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division demonstrated its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.
-
NewsNew antibiotic attacks bacteria in never-before-seen way
Scientists have discovered a new antibiotic that works in a never-before-seen way and may be the next frontliner in the fight against drug-resistant superbugs.
-
NewsStudy finds common infection does not increase risk of recurrent preterm birth
A new study has found that the common sexually transmitted infection, Mycoplasma genitalium, also known as MGen, does not appear to increase the risk of recurrent preterm birth. Earlier research suggested that certain Mycoplasma species might contribute to preterm labor, but those studies were limited.
-
NewsResearchers test two treatments to protect against deadly cattle disease
As cases of a deadly cattle disease rise in Arkansas, researchers are testing two treatments they hope will help ranchers protect their herds. The disease is bovine theileriosis and is caused by the parasite Theileria orientalis Ikeda, carried primarily by the invasive Asian longhorned tick.
-
NewsQ&A: Meet Letters in Applied Microbiology Junior Reviewer Md. Ekramul Karim
We caught up with Md Ekramul Karim, a Ph.D. candidate at the University of Houston, who is one of the newest Junior Reviewers with Letters in Applied Microbiology.
-
NewsFirst-in-human clinical trial shows promising results for new Lassa fever vaccine
Researchers have reported encouraging results from an early clinical trial that tested a new dual vaccine against Lassa fever and rabies. The study found that the vaccine was safe and induced immune responses against both viruses. There are currently no vaccines against Lassa fever on the market.
-
NewsAccelerating chikungunya vaccine development in Africa: Launch of the ACT-CHIK Project
Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.
-
NewsEurope’s crops under threat: €6 million project launches to tackle rising plant pest crisis
The University of Warwick leads a European consortium to build the first platform capable of coordinating Europe’s response to devastating agricultural and forest pest invasions. The project will give plant health authorities the ability to model and optimise pest control strategies across the entire agri-value chain.
-
NewsResearch team awarded NIH grant to study early immune determinants of human tuberculosis infection
A research team was awarded a 5-year, $3.8 million grant to study early immune responses in the lung and how they influence tuberculosis infection outcomes. The program focuses on how lung immune cells called macrophages influence the earliest stages of tuberculosis infection.
-
NewsNew noninvasive tool may allow early detection of dangerous intestinal disease in premature babies
A first-in-human study shows that a handheld probe placed gently on the belly of most fragile infants can reliably identify early stages of necrotizing enterocolitis.
-
NewsTime for an AI checkup: Flaw found in machine learning for sepsis treatment
Researchers found a flaw in many peer-reviewed studies using the AI method known as reinforcement learning as a theoretical guide for the treatment of sepsis. If these flawed systems for sepsis treatment were deployed in a healthcare setting, they would recommend either overtreatment or undertreatment in nearly half of patient states.
-
NewsMost cases of HIV persistence in blood following treatment explained by defective copies of the virus
A study based on blood samples strongly suggests that most persistent cases of viral detection, despite ideal HIV drug therapy, are not due to virus transmission or a rebound of active disease.
-
NewsNew study highlights maternal-fetal TORCH infection risk
Researchers have assessed long-term trends in TORCH infections in India, a region where reliable data have been lacking. TORCH includes pathogens that cause toxoplasmosis, rubella, cytomegalovirus (CMV), herpes simplex virus and other infections.
-
NewsDrug-resistant bacteria found in homes from sewage overflow
A new study shows that sewage overflows in homes can expose people to bacteria that can make them sick, including antibiotic-resistant and multidrug resistant bacteria which can make infections difficult to treat.
-
NewsInfections are major ‘health hazard’ for people with diabetes
Infections should be considered a “health hazard” in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but under-recognised burden of illness, hospitalisation and death. People living with type 1 diabetes, type 2 diabetes and prediabetes face higher risks of infection compared to those without diabetes.
-
NewsMaternal RSV vaccine cuts infant hospitalizations by 70%
A study has found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in young infants by nearly 70%. It provides early real-world evidence from U.S. clinical care, showing that administering one dose of the maternal RSV vaccine (RSVpreF vaccine) reduces hospitalization related to RSV in young infants.
-
NewsData from patients hospitalised with COVID-19 made available to the scientific community
The DIVINE study database has been published. The cohort includes clinical information from 5,813 patients hospitalised with COVID-19 during four waves of the pandemic, between March 2020 and August 2021, across five hospitals in the southern metropolitan area of Barcelona.
-
NewsFever and chills can make respiratory diseases more contagious
A new study reveals that when the difference between body temperature and the ambient temperature is greater, the clouds of particles generated by coughing or sneezing disperse more and maintain a higher concentration.
-
NewsNew model could help track deadly viruses back to their source
A new predictive model could help scientists more efficiently identify the reservoirs of emerging zoonotic viruses and dangerous pathogens like Ebola that can spill over from animals into humans. It relies on detailed information collected on suspected reservoir species to identify key windows.
-
NewsResearcher investigates how a bioengineered peptide can break through harmful bacterial ‘fortresses’ and curb severe infections
A researcher is refining a powerful therapy for drug-resistant bacteria that pierces the gooey coating that anchors and protects such germs from the drugs we take to kill them. She has found that an antimicrobial peptide naturally found in cows weakens the biofilm defenses of Klebsiella pneumoniae bacteria and destroys it.